15 results match your criteria: "Pan American Foot-and-Mouth Disease Center (PANAFTOSA)[Affiliation]"
Front Vet Sci
March 2024
Pan American Foot-and-Mouth Disease Center (PANAFTOSA), Pan American Health Organization, Rio de Janeiro, Brazil.
Amid the surge in data volume generated across various fields of knowledge, there is an increasing necessity for advanced analytical methodologies to effectively process and utilize this information. Particularly in the field of animal health, this approach is pivotal for enhancing disease understanding, surveillance, and management. The main objective of the study was to conduct a comprehensive livestock and environmental characterization of Colombian municipalities and examine their relationship with the distribution of vesicular stomatitis ().
View Article and Find Full Text PDFPLoS Negl Trop Dis
December 2019
Pan-American Foot-and-Mouth Disease Center-PANAFTOSA/PAHO, Duque de Caxias, Rio de Janeiro, Brazil.
Background: Visceral Leishmaniasis (VL) is the most severe form of leishmaniasis because it can lead to death. In the Americas, 96% of cases are in Brazil, and despite efforts, the fatality rate has increased in the past years. We analyzed deaths associated to VL in Brazil and investigated the factors that could influence on the timeliness of fatal outcome with emphasis on time (tStoD).
View Article and Find Full Text PDFTransbound Emerg Dis
March 2019
Pan American Foot-and-Mouth Disease Center (PANAFTOSA), Pan American Health Organization, Regional Office for the Americas of the World Health Organization, Rio de Janeiro, Brazil.
This study investigates the historical temporal trend and geographical distribution of the foot-and-mouth disease virus (FMDv) serotype C in South America; discussing the findings within the context of the actions and strategies carried out for the elimination of foot-and-mouth disease (FMD). This is the first time that such a comprehensive historical compilation has been carried out in the Region; hence, the study is intended as a reference and source of evidence about the presence/absence of FMDv serotype C in South America. Data on the occurrence of FMD were sourced from the Weekly Epidemiological Reports submitted by the countries to Pan American Foot-and-Mouth Disease Center (PANAFTOSA-PAHO/WHO) since 1972, and complemented with other sources of information from the 1968-1971 period.
View Article and Find Full Text PDFTrop Med Infect Dis
August 2018
LYSSA LLC, Cumming, GA 30040, USA.
Rabies virus is the only Lyssavirus species found in the Americas. In discussions about rabies, Latin America and the Caribbean are often grouped together. Our study aimed to independently analyse the rabies situation in the Caribbean and examine changes in rabies spatiotemporal epidemiology.
View Article and Find Full Text PDFPLoS Negl Trop Dis
March 2018
Zoonosis group, Pan American Foot-and-Mouth Disease Center (PANAFTOSA), Pan American Health Organization (PAHO/WHO), Rio de Janeiro, Brazil.
Through national efforts and regional cooperation under the umbrella of the Regional Program for the Elimination of Rabies, dog and human rabies have decreased significantly in Latin America and Caribbean (LAC) countries over the last three decades. To achieve this decline, LAC countries had to develop national plans, and consolidate capabilities such as regular mass dog vaccination, opportune post-exposure prophylaxis and sensitive surveillance. This paper presents longitudinal data for 21 LAC countries on dog vaccination, PEP and rabies surveillance collected from the biannual regional meeting for rabies directors from 1998-2014 and from the Regional Epidemiologic Surveillance System for Rabies (SIRVERA).
View Article and Find Full Text PDFFront Vet Sci
January 2017
Pan American Foot-and-Mouth Disease Center (PANAFTOSA), Pan American Health Organization, Regional Office of the World Health Organization for the Americas (PAHO/WHO) , Rio de Janeiro , Brazil.
In Latin American and Caribbean (LAC) countries, the number of cases of dog-mediated human rabies is at its lowest since the onset of the Regional Program for Rabies Elimination in 1983, a commitment from LAC countries to eliminate dog-mediated rabies coordinated by the Pan American Health Organization. Despite minor setbacks, the decline in the number of human cases has been constant since 1983. While many LAC countries have significantly reduced rabies to a level where it is no longer significant public health concern, elimination has proven elusive and pockets of the disease remain across the region.
View Article and Find Full Text PDFPLoS Negl Trop Dis
November 2016
Pan American Foot-and-Mouth Disease Center-PANAFTOSA/PAHO, Duque de Caxias, Rio de Janeiro, Brazil.
Methods: Cases reported in the period of 2001-2011 from 14/18 CL endemic countries were included in this study by using two spreadsheet to collect the data. Two indicators were analyzed: CL cases and incidence rate. The local regression method was used to analyze case trends and incidence rates for all the studied period, and for 2011 the spatial distribution of each indicator was analyzed by quartile and stratified into four groups.
View Article and Find Full Text PDFLancet Infect Dis
January 2017
International Union Against Tuberculosis and Lung Disease, Paris, France.
Mycobacterium tuberculosis is recognised as the primary cause of human tuberculosis worldwide. However, substantial evidence suggests that the burden of Mycobacterium bovis, the cause of bovine tuberculosis, might be underestimated in human beings as the cause of zoonotic tuberculosis. In 2013, results from a systematic review and meta-analysis of global zoonotic tuberculosis showed that the same challenges and concerns expressed 15 years ago remain valid.
View Article and Find Full Text PDFVaccine
July 2016
Pan-American Foot-and-Mouth Disease Center - PANAFTOSA/PAHO, Av. Governador Leonel de Moura Brizola 7778, Duque de Caxias, RJ CEP 25045-002, Brazil. Electronic address:
Foot-and-Mouth Disease serotype O circulated endemically in Ecuador for many years, with an upsurge occurring in 2009. This manuscript describes retrospectively in vitro and in vivo laboratory studies to predict the field effectiveness of a commercial FMD vaccine to protect against the field strain, and explains the key actions and epidemiological strategies followed by the country to control the disease. The results established that the use of a good quality oil vaccine, manufactured with strains that were isolated long ago: O1 Campos Br/58 and A24 Cruzeiro Br/55; combined with the correct epidemiological strategies, are useful to control field strains when used in periodic biannual vaccination campaigns.
View Article and Find Full Text PDFTransbound Emerg Dis
February 2017
Pan American Foot-and-Mouth Disease Center (PANAFTOSA), Pan American Health Organization, Regional Office for the Americas of the World Health Organization, Rio de Janeiro, Brazil.
South America has a favourable position with respect to foot-and-mouth disease (FMD) compared with other FMD-affected regions due to the elimination of endemic clinical presentation of the disease. South America has reached the final stage of control and aims to eradicate the disease in the region under the provisions of the Hemispheric Program for the Eradication of FMD 2011-2020 (PHEFA). This programme aims at bringing eradication to completion, thereby eliminating the pool of foot-and-mouth disease genotypes active in South America.
View Article and Find Full Text PDFPhilos Trans R Soc Lond B Biol Sci
August 2013
Pan American Foot-and-Mouth Disease Center (PANAFTOSA), Pan American Health Organization, Regional Office for the Americas of the World Health Organization, Avenida Governador Leonel de Moura Brizola, Duque de Caxias CEP 25045-002, Rio de Janeiro, Brazil.
Foot-and-mouth disease (FMD) is a highly transmissible and economically devastating disease of cloven-hoofed livestock. Although vaccines are available and have been instrumental in eliminating the disease from most of the South American animal population, viral circulation still persists in some countries and areas, posing a threat to the advances of the last 60 years by the official veterinary services with considerable support of the livestock sectors. The importance of the disease for the social and economic development of the American continent led to the establishment in 1951 of the Pan American Centre for Foot-and-Mouth Disease (PANAFTOSA), which has been providing technical cooperation to countries for the elimination of the disease.
View Article and Find Full Text PDFInfect Genet Evol
January 2013
Pan American Foot-and-Mouth Disease Center (PANAFTOSA) - PAHO/WHO, Duque de Caxias, RJ, Brazil.
Foot-and-mouth disease virus (FMDV) is the causative agent of the most important disease of domestic cattle, foot-and-mouth disease. In Ecuador, FMDV is maintained at an endemic state, with sporadic outbreaks. To unravel the tempo and mode of FMDV spread within the country we conducted a Bayesian phylogeographic analysis using a continuous time Markov chain (CTMC) to model the diffusion of FMDV between Ecuadorian provinces.
View Article and Find Full Text PDFBiologicals
December 2005
Pan American Foot-and-Mouth Disease Center (PANAFTOSA), PAHO/WHO, PO Box 589, CEP:20010-974 Rio de Janeiro, RJ, Brazil.
The ability of foot-and-mouth disease virus (FMDV) to establish subclinical and even persistent infection, the so called carrier state, imposes the need to reliably demonstrate absence of viral circulation, to monitor the progress of control measures, either during eradication programs or after reintroduction of virus in free areas. This demonstration becomes critical in immunized populations, because of the concern that silent viral circulation could be hidden by immunization. This concern originates from the fact that vaccination against foot-and-mouth disease (FMD) protects against clinical disease, but not necessarily against subclinical infection or establishment of the carrier state in cattle.
View Article and Find Full Text PDFDev Biol (Basel)
June 2005
Pan American Foot-and-Mouth Disease Center (PANAFTOSA) PAHO/WHO, Rio de Janeiro, RJ, Brasil.
Vaccination against foot-and-mouth disease (FMD) constitutes an important component of the policy for its control and eradication in South America. Considering that immunization may not impair subclinical infection, it became advisable to ally to vaccination campaigns a surveillance instrument to monitor silent viral circulation. Novel approaches for the evaluation of antibodies to FMD non-capsid proteins (NCPs), developed and validated at PANAFTOSA proved valuable for assessing viral circulation in immunized populations.
View Article and Find Full Text PDFBovine, equine and swine sera from areas free from vesicular stomatitis virus (VSV) Indiana 3 (IND3)--namely Argentina, Chile, Italy and Uruguay--and endemic areas (in Brazil) were examined for anti-VSV IND3 virus antibodies in order to compare results obtained using the virus neutralisation (VN) test and liquid-phase blocking enzyme-linked immunosorbent assay (ELISA). Statistical analysis of the data showed close agreement between the two techniques (K = 0.92).
View Article and Find Full Text PDF